Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2012 1
2013 3
2014 1
2015 1
2016 1
2018 2
2019 2
2020 1
2021 1
2022 1
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
A Prospective Randomized Multicenter Study on the Impact of [18F]F-Choline PET/CT Versus Conventional Imaging for Staging Intermediate- to High-Risk Prostate Cancer.
Evangelista L, Zattoni F, Burei M, Bertin D, Borsatti E, Baresic T, Farsad M, Trenti E, Bartolomei M, Panareo S, Urso L, Trifirò G, Brugola E, Chierichetti F, Donner D, Setti L, Gallan M, Del Bianco P, Magni G, De Salvo GL, Novara G; Study Group Coinvestigators. Evangelista L, et al. Among authors: burei m. J Nucl Med. 2024 Jul 1;65(7):1013-1020. doi: 10.2967/jnumed.123.267355. J Nucl Med. 2024. PMID: 38844361 Clinical Trial.
Bone metastases from neuroendocrine tumors: clinical and biological considerations.
Scopel M, De Carlo E, Bergamo F, Murgioni S, Carandina R, Cervino AR, Burei M, Vianello F, Zagonel V, Fassan M, Vettor R. Scopel M, et al. Among authors: burei m. Endocr Connect. 2022 Jun 27;11(7):e210568. doi: 10.1530/EC-21-0568. Print 2022 Jul 1. Endocr Connect. 2022. PMID: 35671272 Free PMC article.
BCR kinase inhibitors, idelalisib and ibrutinib, are active and effective in Richter syndrome.
Visentin A, Imbergamo S, Scomazzon E, Pravato S, Frezzato F, Bonaldi L, Pizzi M, Vio S, Gregianin M, Burei M, Facco M, Semenzato G, Piazza F, Trentin L. Visentin A, et al. Among authors: burei m. Br J Haematol. 2019 Apr;185(1):193-197. doi: 10.1111/bjh.15440. Epub 2018 Jul 5. Br J Haematol. 2019. PMID: 29974955 Free article. No abstract available.
ITA-IMMUNO-PET: The Role of [18F]FDG PET/CT for Assessing Response to Immunotherapy in Patients with Some Solid Tumors.
Evangelista L, Bianchi A, Annovazzi A, Sciuto R, Di Traglia S, Bauckneht M, Lanfranchi F, Morbelli S, Nappi AG, Ferrari C, Rubini G, Panareo S, Urso L, Bartolomei M, D'Arienzo D, Valente T, Rossetti V, Caroli P, Matteucci F, Aricò D, Bombaci M, Caponnetto D, Bertagna F, Albano D, Dondi F, Gusella S, Spimpolo A, Carriere C, Balma M, Buschiazzo A, Gallicchio R, Storto G, Ruffini L, Cervati V, Ledda RE, Cervino AR, Cuppari L, Burei M, Trifirò G, Brugola E, Zanini CA, Alessi A, Fuoco V, Seregni E, Deandreis D, Liberini V, Moreci AM, Ialuna S, Pulizzi S, De Rimini ML. Evangelista L, et al. Among authors: burei m. Cancers (Basel). 2023 Jan 31;15(3):878. doi: 10.3390/cancers15030878. Cancers (Basel). 2023. PMID: 36765835 Free PMC article.
Detection rate of 18F-Choline positron emission tomography/computed tomography in patients with non-metastatic hormone sensitive and castrate resistant prostate cancer.
Zattoni F, Artioli P, Burei M, Chiaravalloti A, Chierichetti F, Donner D, Panareo S, Rambaldi I, Schillaci O, Dal Moro F, Evangelista L. Zattoni F, et al. Among authors: burei m. Q J Nucl Med Mol Imaging. 2023 Jun;67(2):167-173. doi: 10.23736/S1824-4785.21.03366-5. Epub 2021 Sep 3. Q J Nucl Med Mol Imaging. 2023. PMID: 34477346
18 results